Javascript must be enabled to continue!
Differentially Expressed MicroRNAs Associated with Vein Graft Restenosis in Rats
View through CrossRef
Objective: Intimal hyperplasia is the main cause of restenosis of vein grafts after venous transplantation. MicroRNAs are considered to play a role in vein graft restenosis; however, the expression profile of microRNAs in neointima has not been reported in detail. We wanted to investigate the differentially expressed microRNAs in the restenosis of vein grafts in rats.
Methods: We established a rat model for vein transplantation to explore the pathogenic roles of microRNAs during intimal hyperplasia. Hematoxylin and eosin staining was used to confirm intimal hyperplasia in the vein grafts. Changes in microRNA expression in the vein grafts were detected 3 and 14 days after surgery by sequencing, reverse transcription–quantitative polymerase chain reaction, and bioinformatics analyses for functional annotation.
Results: We detected 711 newly predicted microRNAs among all the comparisons. Among these comparisons, 437 differentially expressed microRNAs were detected in the postoperative day 3 group versus the control group, 265 were detected in the postoperative day 14 group versus the control group, and 158 were detected in the postoperative day 14 group versus the postoperative day 3 group. Pathway analysis revealed significant enrichment of target genes that mediate Wnt, mitogen-activated protein kinase, vascular smooth muscle contraction, and regulation of actin cytoskeleton signaling.
Conclusion: Our results provide insight into the pathogenesis of restenosis and will help develop novel targets in the prevention and treatment of vein graft restenosis.
Title: Differentially Expressed MicroRNAs Associated with Vein Graft Restenosis in Rats
Description:
Objective: Intimal hyperplasia is the main cause of restenosis of vein grafts after venous transplantation.
MicroRNAs are considered to play a role in vein graft restenosis; however, the expression profile of microRNAs in neointima has not been reported in detail.
We wanted to investigate the differentially expressed microRNAs in the restenosis of vein grafts in rats.
Methods: We established a rat model for vein transplantation to explore the pathogenic roles of microRNAs during intimal hyperplasia.
Hematoxylin and eosin staining was used to confirm intimal hyperplasia in the vein grafts.
Changes in microRNA expression in the vein grafts were detected 3 and 14 days after surgery by sequencing, reverse transcription–quantitative polymerase chain reaction, and bioinformatics analyses for functional annotation.
Results: We detected 711 newly predicted microRNAs among all the comparisons.
Among these comparisons, 437 differentially expressed microRNAs were detected in the postoperative day 3 group versus the control group, 265 were detected in the postoperative day 14 group versus the control group, and 158 were detected in the postoperative day 14 group versus the postoperative day 3 group.
Pathway analysis revealed significant enrichment of target genes that mediate Wnt, mitogen-activated protein kinase, vascular smooth muscle contraction, and regulation of actin cytoskeleton signaling.
Conclusion: Our results provide insight into the pathogenesis of restenosis and will help develop novel targets in the prevention and treatment of vein graft restenosis.
Related Results
Identification of microRNAs involved in early vein graft remodelling
Identification of microRNAs involved in early vein graft remodelling
Abstract
Background
The saphenous vein (SV) is the most commonly-used conduit for coronary artery bypass grafting (CABG)....
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. The first percutaneous coronary intervention was performed by Andreas Gruntzig on Septemb...
Six-Month Angiographic Outcome After Successful Repeat Percutaneous Intervention for In-Stent Restenosis
Six-Month Angiographic Outcome After Successful Repeat Percutaneous Intervention for In-Stent Restenosis
Background
—In-stent restenosis is an increasing clinical problem. Discordant results have been published regarding the risk of recurrent restenosis after repeat angiop...
4079The future of recurring restenosis prediction - Urinary cysteinyl leukotriene e4
4079The future of recurring restenosis prediction - Urinary cysteinyl leukotriene e4
Abstract
Background
Peripheral artery disease (PAD) is one of the common atherosclerosis manifestations. However endovascular tr...
Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
Restenosis rate after multiple percutaneous transluminal coronary angioplasty procedures at the same site. A quantitative angiographic study in consecutive patients undergoing a third angioplasty procedure for a second restenosis.
BACKGROUND
Several studies suggest that repeated percutaneous transluminal coronary angioplasty procedures at the same site are associated with a progressively increasi...
Effect of Graft Shift Direction on Graft Detachment and Endothelial Cell Survival After Descemet Membrane Endothelial Keratoplasty
Effect of Graft Shift Direction on Graft Detachment and Endothelial Cell Survival After Descemet Membrane Endothelial Keratoplasty
Purpose:
To investigate the effects of graft shift orientation on clinical outcomes after Descemet membrane endothelial keratoplasty (DMEK).
...
Restenosis after Percutaneous Balloon Mitral Valvuloplasty in Patients with Previous Surgery
Restenosis after Percutaneous Balloon Mitral Valvuloplasty in Patients with Previous Surgery
To identify the risk factors of restenosis after balloon mitral valvuloplasty in patients with mitral restenosis after surgical valvotomy, we obtained 30.4 ± 13.0 months (range 6 t...
Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection
Abstract
Background
Recent reports have shown that patients with vascular tumour invasion who undergo concurrent vascular resect...

